Phase 1 Trial for Potential Alzheimer’s Therapy Yields Positive Results
Alzheimer's disease, Alzheimer's News, News
A recent Phase 1 clinical study of a potential Alzheimer’s therapy showed positive results regarding both safety and biomarkers for cognitive processes. The data support advancing the investigational compound, NDX-1017, ... Read more